(Q43866165)

English

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age.

scientific article published on 28 November 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP.IPV/PRP-T Hib and hepatitis B vaccines in infants 2-7 months of age. (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hepatitis B vaccine

1 reference

based on heuristic

inferred from title

Scott A Halperin

2

object named as

Scott A Halperin

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

David W Scheifele

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Bruce Smith

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Jan Ochnio

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Keith Meloff

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Denzyl Duarte-Monteiro

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

28 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

2057-2064

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Population-based impact of pneumococcal conjugate vaccine in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus B conjugate vaccine administered to infants at two, four and six months of age

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Immunogenicity of a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine when mixed with a diphtheria-tetanus-acellular pertussis-hepatitis B combination vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Safety and immunogenicity of Haemophilus influenzae-tetanus toxoid conjugate vaccine given separately or in combination with a three-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate and hepatitis B vacci

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Safety and immunogenicity of a combination diphtheria-tetanus toxoids-acellular pertussis-hepatitis B vaccine administered at two, four and six months of age compared with monovalent hepatitis B vaccine administered at birth, one month and six month

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Invasive Haemophilus influenzae type b infections in vaccinated and unvaccinated children in Canada, 2001-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus protein--conjugated pneumococcal vaccine in Filipino infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Comparative immunogenicity of hepatitis B vaccine administered into the ventrogluteal area and anterolateral thigh in infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.021

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.11.021

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43866165&oldid=2104019843"